And we do have a more direct line of sight to our profitability going forward. Then, just a few more thoughts as we committed at the May Investor Day, we do intend to improve our margins over time. And one component of that improvement is continuously refining our cost structure and carefully managing it as we grow revenue. We’ve been giving our cost structure, I’d say even more attention recently, given the pressures of inflation that I covered in my prepared remarks. I should also mention that our strategies to grow a higher mix of clinical and technology work, which can drive higher margins over time, we believe that support higher margins. And then we’ll just one last indicator I’ll point out is for our outside the U.S. segment, despite a difficult year, it finished profitable in the fourth quarter.
And while we’re not satisfied with the margin that it posted, and we have more work to do, it does give me confidence that we can deliver more stability in that segment.
Charlie Strauzer: And then, Bruce, can you just be tying back to your comments about the pipeline and the strategic refresh that you talked about at the Investor Day. Maybe some more granularity or insight as to what you’re seeing in the business the green shoots from that?
Bruce Caswell: Let’s start back with the pipeline. As I mentioned in my prepared remarks. The pipeline as of September 30 was $30.7 billion. And I’m pleased that 74% of that represents new work. And within that 57% of the total pipeline is in the U.S. federal services segment. So very strong pipeline in federal services. Two areas where we’re seeing a number of green shoots. I like that term. I’ll pick it up from you. Our clinical assessments and technology solutions supporting IT modernization initiatives from federal agencies. So I’ll start with the former. We’re seeing opportunities across federal agencies beyond the VA, supporting areas such as fitness for duty exams and other areas related to occupational health for federal employees as an example.
At the state level, we’re also seeing more state Medicaid agencies bring together assessments related to Medicaid populations that have historically been done by multiple parties, and they bring them together into consolidated RFPs, which obviously are very attractive to us. Both of those types of areas of work and opportunity are well suited to Maximus through the prior acquisitions that we did, beginning with a send you a number of years ago in 2015, 2016, if I recall correctly, but then also, most recently, the veterans evaluation services acquisition. Regarding the latter area that I mentioned, which is technology solutions, supporting IT modernization, we are seeing continued budgeted resources in RFP development and procurements related to IT modernization initiatives across a number of federal civilian agencies, the one that’s been in the press, probably the most, is the IRS.
And that’s been kind of most publicized in his numerous term. And while there are many vendors in this space, it is a crowded market, we feel that we’re very well positioned from a reputation and capabilities perspective again, really thrilled with how we’ve developed in this area as a consequence of the attained federal acquisition. Finally, I think find most encouraging is how we’re starting to see a lot of collaboration across the business, in the sales functions and the solution development teams to pull through capabilities from one segment to another. So I’ll give you a quick example. A small example of how we’re leveraging our market leading experience in U.S. services in our capabilities in Medicaid eligibility and enrollment as we look at things like health benefit enrollment processes for federal employees.
